YU242390A - Matrica s celicami, vezanimi nanjo adherentno, kot tudi postopek za proizvodnjo virusa/virusantigena - Google Patents

Matrica s celicami, vezanimi nanjo adherentno, kot tudi postopek za proizvodnjo virusa/virusantigena

Info

Publication number
YU242390A
YU242390A YU242390A YU242390A YU242390A YU 242390 A YU242390 A YU 242390A YU 242390 A YU242390 A YU 242390A YU 242390 A YU242390 A YU 242390A YU 242390 A YU242390 A YU 242390A
Authority
YU
Yugoslavia
Prior art keywords
virus
cells
antigen
bound
matrix
Prior art date
Application number
YU242390A
Other languages
English (en)
Inventor
Wolfgang Mundt
Noel Barrett
Friedrich Dorner
Johann Eibl
Original Assignee
Immuno Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Aktiengesellschaft filed Critical Immuno Aktiengesellschaft
Priority to HRP921354 priority Critical patent/HRP921354A2/xx
Publication of YU242390A publication Critical patent/YU242390A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2531/00Microcarriers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24111Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151Methods of production or purification of viral material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

Izum se nanaša na matrico, torej nosilni material, z nanjo adherentno vezanimi človeškimi ali živalskimi celicami, pri čemer so celice inficirane z virusom. Pokazalo se je, da od površine odvisne celice, primerne za razmnoževanje virusa, ostanejo celo v stanju, inficiranem z virusom, adherentno vezane na matrici, da sorazmerno dolgo časa kontinuirno proizvajajo virusantigen in ga oddajajo v gojilni medij. Za proizvodnjo virusantigena zgodnjega poletnega meningoencefalitisa (FSME) z gojenjem FSME-virusa v celičnih kulturah cepimo od površine odvisno, permanentno celično linijo, prednostno Vero-celično linijo ATTC CCL 81, FSME-virusom ter vzdržujemo celice ob vzdrževanju celične rasti v ne-litičnem sistemu brez seruma vezane na nosilcih, da vzdržujemo tvorbo antigena, nakar ločimo antigen vsebujoči medij od celic, vezanih na nosilcu, ter na znan način obdelamo s koncentriranjem, dezaktiviranjem in čiščenjem v galensko sprejemljiv pripravek.
YU242390A 1989-12-22 1990-12-21 Matrica s celicami, vezanimi nanjo adherentno, kot tudi postopek za proizvodnjo virusa/virusantigena YU242390A (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HRP921354 HRP921354A2 (en) 1989-12-22 1992-11-25 Matrix with cells adherently bounded to it, and the process for the production of viruses/virus antigenes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT2928/89A AT393356B (de) 1989-12-22 1989-12-22 Verfahren zur herstellung von fsme-virus-antigen

Publications (1)

Publication Number Publication Date
YU242390A true YU242390A (sh) 1993-05-28

Family

ID=3542524

Family Applications (1)

Application Number Title Priority Date Filing Date
YU242390A YU242390A (sh) 1989-12-22 1990-12-21 Matrica s celicami, vezanimi nanjo adherentno, kot tudi postopek za proizvodnjo virusa/virusantigena

Country Status (16)

Country Link
EP (1) EP0506714B1 (sh)
JP (1) JP2633391B2 (sh)
AT (2) AT393356B (sh)
CA (1) CA2071954C (sh)
CZ (1) CZ281804B6 (sh)
DE (1) DE59007659D1 (sh)
DK (1) DK0506714T3 (sh)
ES (1) ES2067916T3 (sh)
FI (1) FI98377C (sh)
HR (1) HRP921354A2 (sh)
HU (1) HU213886B (sh)
NO (1) NO310305B1 (sh)
RU (1) RU2082757C1 (sh)
SK (1) SK659090A3 (sh)
WO (1) WO1991009935A1 (sh)
YU (1) YU242390A (sh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2378409T3 (es) * 1994-11-10 2012-04-12 Baxter Healthcare S.A. Método para producir sustancias biológicas en cultivo sin proteínas
FR2737412B1 (fr) * 1995-08-01 1997-10-24 Pasteur Merieux Serums Vacc Procede de production d'un vaccin contre le virus de l'encephalite japonaise et vaccin obtenu par ce procede
KR19990036028A (ko) * 1995-08-01 1999-05-25 다니엘 케르니 일본뇌염 백신의 공업적인 생산방법 및 이에 의한 백신
JP4371343B2 (ja) * 1998-10-05 2009-11-25 財団法人阪大微生物病研究会 日本脳炎ウイルス群感染症に対する不活化ワクチンのための増強免疫原およびその製造方法
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
US6855535B2 (en) * 2001-12-10 2005-02-15 Baxter Healthcare S.A. Method of large scale production of Hepatitis A virus
US6951752B2 (en) * 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen
JP2007068401A (ja) * 2003-08-07 2007-03-22 Chemo Sero Therapeut Res Inst 西ナイルウイルスワクチン
PT2574677T (pt) * 2007-12-27 2017-10-19 Baxalta Inc Processos para cultura de células

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT358167B (de) * 1978-12-22 1980-08-25 Immuno Ag Verfahren zur herstellung von fruehsommer- -meningoenzephalitis-virus (fsme-virus)- -vakzinen
SE445116B (sv) * 1979-09-12 1986-06-02 Pharmacia Fine Chemicals Ab Sett att odla celler pa mikroberare med fibronektinytskikt
NO161446C (no) * 1981-03-13 1989-08-16 Damon Biotech Inc Fremgangsmaate for dyrking av celler som er avhengige av forankring.
SE8103138L (sv) * 1981-05-19 1982-11-20 Pharmacia Fine Chemicals Ab Mikroberare for odling av forankringsberoende celler
CA1206900A (en) * 1981-12-21 1986-07-02 Raymond L. Downs Hollow glass shell microcarrier for growth of cell cultures, and method of shell manufacture
AT385203B (de) * 1985-04-26 1988-03-10 Immuno Ag Verfahren zur herstellung einer fruehsommermeningoenzephalitis-virus (fsme-virus)-vakzine
DD274336A3 (de) * 1985-10-03 1989-12-20 Npo Biolar Verfahren zur Gewinnung einer Mikroträgersubstanz für die Zellkultivierung

Also Published As

Publication number Publication date
DK0506714T3 (da) 1995-04-18
DE59007659D1 (de) 1994-12-08
ATA292889A (de) 1991-03-15
FI922851A (fi) 1992-06-18
JP2633391B2 (ja) 1997-07-23
HU9202009D0 (en) 1992-10-28
AT393356B (de) 1991-10-10
ES2067916T3 (es) 1995-04-01
EP0506714A1 (de) 1992-10-07
EP0506714B1 (de) 1994-11-02
RU2082757C1 (ru) 1997-06-27
CZ659090A3 (en) 1996-11-13
CA2071954A1 (en) 1991-06-23
WO1991009935A1 (de) 1991-07-11
CA2071954C (en) 1996-06-18
HU213886B (en) 1997-11-28
FI922851A0 (fi) 1992-06-18
HRP921354A2 (en) 1996-02-29
HUT65410A (en) 1994-06-28
ATE113652T1 (de) 1994-11-15
FI98377C (fi) 1997-06-10
SK279236B6 (sk) 1998-08-05
SK659090A3 (en) 1998-08-05
FI98377B (fi) 1997-02-28
NO922422L (no) 1992-08-17
JPH05502581A (ja) 1993-05-13
NO922422D0 (no) 1992-06-19
NO310305B1 (no) 2001-06-18
CZ281804B6 (cs) 1997-02-12

Similar Documents

Publication Publication Date Title
HK1019233A1 (en) Animal cells and processes for the replication of influenza viruses
Sugiura et al. Genetic studies of influenza viruses: II. Plaque formation by influenza viruses in a clone of a variant human heteroploid cell line
PT88178A (pt) Metodo para a purificacao de virus da hepatite a
DE69626022D1 (de) Verfahren zur industriellen herstellung eines japanischen enkephalitis impfstoffes, und so erhaltener impfstoff
YU242390A (sh) Matrica s celicami, vezanimi nanjo adherentno, kot tudi postopek za proizvodnjo virusa/virusantigena
NZ197553A (en) Production of antigens specific to r.s.v.;cell lines bearing these antigens and pharmaceutical compositions
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
Kingsbury Use of actinomycin D to unmask RNA synthesis induced by Newcastle disease virus
ES8200227A1 (es) Procedimiento de obtencion de vacunas de bronquitis in- fecciosa para aves de corral
US4169761A (en) Process for the cultivation of viruses
Takemoto et al. Influence of acid polysaccharides on plaque formation by influenza A2 and B viruses
ES8105930A1 (es) Procedimiento para la preparacion de vacunas de virus poli- valentes
Otsuki et al. Plaque formation by avian infectious bronchitis virus in primary chick embryo fibroblast cells in the presence of trypsin
US4433052A (en) Process for producing interferon
US3228840A (en) Virus culture
US3418210A (en) Hamster ascites tumor cell line bhk 21/c.13/t.6/ascites useful in submerged serum-free agar cultures to support virus growth
Grabowska et al. A sensitive method for NDV isolation using media modified by 5-iodo-2-deoxyuridine(IDU).
RU2242512C1 (ru) Штамм вируса западного энцефаломиелита лошадей (western encephalomyelitis virus-wee 163-a) гкв № 964 для приготовления диагностических и профилактических препаратов
Wu Studies on the Cultivation of Human Diploid Cells in Microcarrier Culture.
Iinuma Superinfection of HVJ carrier HeLa cells with ultraviolet-irradiated Newcastle disease virus
Mazurkova et al. Optimization of Reproduction Conditions of the Vaccine Cold-Adapted Recombinant Strains of Influenza Virus in Roller-Cultivated MDCK Cells
TH1371B (th) กรรมวิธีสำหรับเตรียมวัคซีนป้องกันโรคกลัวน้ำ
MIR CHAMSY et al. A new Overlay for Plaquing Animal Viruses
CA2250714A1 (en) Animal cells and processes for the replication of influenza viruses